TNT Is Viable for Locally Advanced Rectal Cancer
CR was 36% in the total neoadjuvant therapy cohort vs 21% in the cohort that received chemoradiotherapy with adjuvant chemotherapy.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Colorectal Cancer | Legislation | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Rectal Cancers